Predictors of relapse in a fixed-dose, randomized, double-blind, 52-week relapse prevention trial of selegiline transdermal system

被引：0
|
作者：
Patkar, A. [1 ]
Jang, S. [1 ]
Jung, S. [1 ]
Pae, C. [1 ]
Jae, Y. [1 ]
Portland, K. [2 ]
机构：
[1] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC 27706 USA
[2] Dey Pharma LP, Med Affairs, Basking Ridge, NJ USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2012年 / 22卷
关键词：
D O I：
10.1016/S0924-977X(12)70380-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S254 / S254
页数：1
相关论文
共 50 条
  • [11] Crossover, Double-Blind, Unicentric, 52-Week Trial of Liraglutide in Type 1 Diabetes
    Dube, Marie-Christine
    D'Amours, Martin
    Weisnagel, S. John
    DIABETES, 2016, 65 : A76 - A77
  • [12] The selegiline transdermal system: cardiovascular safety from a randomized, double-blind, placebo-controlled trial.
    Zimbroff, DL
    Feiger, AD
    PHARMACOTHERAPY, 2005, 25 (10): : 1487 - 1487
  • [13] Duloxetine Versus Placebo in Patients With Chronic Low Back Pain A 12-Week, Fixed-Dose, Randomized, Double-Blind Trial
    Skljarevski, Vladimir
    Zhang, Shuyu
    Desaiah, Durisala
    Alaka, Karla J.
    Palacios, Santiago
    Miazgowski, Tomasz
    Patrick, Kyle
    JOURNAL OF PAIN, 2010, 11 (12): : 1282 - 1290
  • [14] RANITIDINE AND CIMETIDINE IN PREVENTION OF DUODENAL-ULCER RELAPSE - A DOUBLE-BLIND, RANDOMIZED, MULTICENTER, COMPARATIVE TRIAL
    GOUGH, KR
    BARDHAN, KD
    CROWE, JP
    KORMAN, MG
    LEE, FI
    REED, PI
    SMITH, RN
    LANCET, 1984, 2 (8404): : 659 - 662
  • [15] RANITIDINE AND CIMETIDINE IN PREVENTION OF DUODENAL-ULCER RELAPSE - A DOUBLE-BLIND, RANDOMIZED, MULTICENTER, COMPARATIVE TRIAL
    GOUGH, KR
    BARDHAN, KD
    CROWE, JP
    KORMAN, MG
    LEE, FI
    REED, PI
    SMITH, RN
    FORTSCHRITTE DER MEDIZIN, 1985, 103 (37) : 878 - 882
  • [16] Single Injection of Cross-Linked Hyaluronate in Knee Osteoarthritis: A 52-Week Double-Blind Randomized Controlled Trial
    Ko, Po-Yen
    Li, Chung-Yi
    Li, Chia-Lung
    Kuo, Li-Chieh
    Su, Wei-Ren
    Jou, I-Ming
    Wu, Po-Ting
    PHARMACEUTICS, 2022, 14 (09)
  • [17] SSRIs and ejaculation: A double-blind, randomized, fixed-dose study with paroxetine and citalopram
    Waldinger, MD
    Zwinderman, AH
    Olivier, B
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (06) : 556 - 560
  • [18] Antidepressants and ejaculation: A double-blind, randomized, fixed-dose study with mirtazapine and paroxetine
    Waldinger, MD
    Zwinderman, AH
    Olivier, B
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (05) : 467 - 470
  • [19] CHARACTERISTICS ASSOCIATED WITH RELAPSE IN PATIENTS WITH SCHIZOPHRENIA: POST HOC ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CARIPRAZINE RELAPSE PREVENTION TRIAL
    Kunovac, Jelena
    Kane, John
    Durgam, Suresh
    Chang, Cheng-Tao
    Nemeth, Gyorgy
    Laszlovszky, Istvan
    Earley, Willie
    SCHIZOPHRENIA BULLETIN, 2017, 43 : S165 - S166
  • [20] Olanzapine versus placebo: Results of a double-blind, fixed-dose olanzapine trial
    Beasley, CM
    Sanger, T
    Satterlee, W
    Tollefson, G
    Tran, P
    Hamilton, S
    Green, A
    Dott, S
    Pfister, G
    Roxas, L
    Small, J
    Thomas, M
    Ames, D
    Schooler, N
    Baker, R
    Levine, R
    Fabre, L
    Friedel, R
    Safferman, A
    Lieberman, J
    Stahl, S
    PSYCHOPHARMACOLOGY, 1996, 124 (1-2) : 159 - 167
12345